Fundz

Bio Consortia, Inc. reported raising $8 Million in an initial SEC Form D filing, from an offering of $8 Million

PRIVATEOct 27, 2016

Amount Raised

$8 Million

$8 Million sold, per SEC Form D (first sale Oct 27, 2016)

Round Type

Venture

DavisOtherBiotechnology

Quick answer

BioConsortia raised $8 Million in a funding round, dated October 27, 2016. BioConsortia is based in Davis, California, United States.

How much did BioConsortia raise?
BioConsortia raised $8 Million in a funding round on October 27, 2016.
What does BioConsortia do?
BioConsortia, Inc. is revolutionizing agriculture with cutting-edge microbial solutions that boost plant health, increase yields, and promote sustainability.
Where is BioConsortia based and how big is it?
BioConsortia is based in Davis, California, United States. Fundz records about 11 employees.
Who are the decision-makers at BioConsortia?
Fundz holds 1 contact at BioConsortia, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as BioConsortia that raised within 45 days of this round, from Fundz verified event records.

Who to call at BioConsortia, and when

A new round usually means BioConsortia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioConsortia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioConsortia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioConsortia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioConsortia

Location

1940 Research Park Drive

Davis, California, United States

About

BioConsortia, Inc. is revolutionizing agriculture with cutting-edge microbial solutions that boost plant health, increase yields, and promote sustainability. As leaders in gene editing and directed selection of microbes, BioConsortia harnesses the power of robust, spore-forming bacteria to develop innovative seed treatments and foliar products. The company’s proprietary Advanced Microbial Selection (AMS) process and GenePro genomics platform enable BioConsortia scientists to identify, design, and enhance microbes that help unlock the full potential of crop plants.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioConsortia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMarcus M., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BioConsortia's next move

See what Strategic adds

BioConsortia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.